Abstract
The aim of this study was to evaluate the effectiveness of intravenous corticosteroid therapy when Henoch–Schönlein purpura (HSP) patients are unable to tolerate oral medications due to abdominal pain. We retrospectively analyzed 111 children with a diagnosis of HSP (mean age 6.9 ± 2.3 years, male:female = 54:57) from the years 2000 to 2007. They were divided into two groups: 49 patients received only oral prednisolone (PL group) and 62 patients received oral prednisolone after intravenous dexamethasone (Dexa + PL group). Palpable purpura was seen in all 111 patients (100%), abdominal pain in 55 (50%), and arthralgia in 65 (59%). Dexa + PL group had significantly longer duration of fasting than PL group (0.7 ± 1.2 vs. 0.02 ± 0.1 days, P < 0.01) due to more severe and frequent abdominal pain (68 vs. 27%, P < 0.01). Intravenous dexamethasone resulted in the rapid resolution of abdominal pain or arthralgia in all patients without major complications. However, the development of nephritis (21% in PL group versus 32% in Dexa + PL group, P = 0.098), the number of relapse (4 vs. 11%, P = 0.167), and persistent nephritis at last follow-up (12 vs. 16%, P = 0.563) were not different between the two groups despite more severe symptoms in Dexa + PL group. Intravenous dexamethasone followed by oral prednisolone may be a useful and effective therapeutic strategy in HSP children who cannot tolerate oral medications due to severe abdominal pain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Koutkia P, Mylonakis E, Rounds S, Erickson A (2001) Leucocytoclastic vasculitis: an update for the clinician. Scand J Rheumatol 30:315–322
Davin J-C, Weening JJ (2001) Henoch–Schonlein purpura nephritis: an update. Eur J Pediatr 160:689–695
Rosenblum ND, Winter HS (1987) Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura. Pediatrics 79:1018–1021
Haroon M (2005) Should children with Henoch-Schonlein purpura and abdominal pain be treated with steroids? Arch Dis Child 90:1196–1198
Mollica F, Li Volti S, Garozzo R, Russo G (1992) Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 151:140–144
Saulsbury FT (1993) Corticosteroid therapy does not prevent nephritis in Henoch Schönlein Purpura. Pediatr Nephrol 7:69–71
Bayrakci US, Topaloglu R, Soylemezoglu O, Kalyoncu M, Ozen S, Besbas N et al (2007) Effect of early corticosteroid therapy on development of Henoch-Schönlein nephritis. J Nephrol 20:406–409
Huber AM, King J, McLaine P, Klassen T, Pothos M (2004) A randomized, placebo-controlled trial of prednisone in early Henoch Schönlein Purpura. BMC Med 2:7
Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J et al (2006) Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 149:241–247
Weiss PF, Feinstein JA, Luan X, Burnham JM, Feudtner C (2007) Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review. Pediatrics 120:1079–1087
Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC et al (2006) EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65:936–941
Kaku Y, Nohara K, Honda S (1998) Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors. Kidney Int 53:1755–1759
Rigante D, Candelli M, Federico G, Bartolozzi F, Porri MG, Stabile A (2005) Predictive factors of renal involvement or relapsing disease in children with Henoch-Schönlein purpura. Rheumatol Int 25:45–48
Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F et al (2005) Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 35:143–153
Gonzalez-Gay MA, Llorca J (2005) Controversies on the use of corticosteroid therapy in children with Henoch-Schönlein purpura. Semin Arthritis Rheum 35:135–137
Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Hwang DH (2006) Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura. Scand J Rheumatol 35:56–60
Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202
Shin JI, Lee JS (2008) Can corticosteroid therapy alter the course of nephritis in children with Henoch-Schönlein purpura? Nat Clin Pract Rheumatol 4:126–127
Shin JI, Lee JS (2006) Comment on: controversies on the use of corticosteroid therapy in children with Henoch-Schonlein purpura. Semin Arthritis Rheum 35:407
Cho CS, Min JK, Park SH, Yang HI, Lee SH, Choi YJ et al (1996) Protein losing enteropathy associated with Henoch-Schönlein purpura in a patient with rheumatoid arthritis. Scand J Rheumatol 25:334–336
Ronkainen J, Koskimies O, Ala-Houhala M et al (2004) Renal symptoms and protein-losing enteropathy in children with Henoch-Schonlein purpura. Pediatr Nephrol 19:C161 (abstract)
Acknowledgments
This study was supported by Research Grant from the NHIC Ilsan Hospital and was poster presented in the 41st Annual Meeting of the American Society of Nephrology, Renal Week; November 4–9, 2008 in Philadelphia, USA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shin, J.I., Lee, S.J., Lee, J.S. et al. Intravenous dexamethasone followed by oral prednisolone versus oral prednisolone in the treatment of childhood Henoch–Schönlein purpura. Rheumatol Int 31, 1429–1432 (2011). https://doi.org/10.1007/s00296-010-1507-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-010-1507-1